Gastric MALT lymphoma: From aetiology to treatment

Lancet Oncology

Volumn 3, Issue 2, 2002, Pages 97-104

  Du, Ming Qing ^a,b   Isaccson, Peter G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; OXYGEN RADICAL; PROTEIN BCL X; PROTEIN P16; PROTEIN P35;

B LYMPHOCYTE; BACTERIAL COLONIZATION; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CHROMOSOME TRANSLOCATION 2; CONTROLLED STUDY; GENE INACTIVATION; GENETIC DISORDER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEUTROPHIL CHEMOTAXIS; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRISOMY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0036182049     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(02)00651-4     Document Type: Review

References (74)

1. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B cell lymphoma
2. Primary gastric B-cell lymphoma: Results of a prospective multicenter study
3. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed
4. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
5. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma
6. Brief report: A single neoplastic clone in sequential biopsy specimens from a patient with primary gastric-mucosa-associated lymphoid-tissue lymphoma and Sjögren's syndrome
7. Preferential dissemination of B cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone
8. Low-grade gastric B cell lymphoma of mucosa-associated lymphoid tissue (MALT): A multifocal disease
9. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa
10. Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma
11. Helicobacter pylori-associated gastritis and primary B cell gastric lymphoma
12. Helicobacter heilmannii gastritis: Association with acid peptic diseases and comparison with Helicobacter pylori gastritis
13. High incidence of primary gastric lymphoma in northeastern Italy
14. Helicobacter pylori infection and gastric lymphoma
15. The response of cells from low-grade B cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
16. Regression of primary low-grade B cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
17. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue
18. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation
19. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
20. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type
21. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis
22. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis
23. Ongoing mutation in MALT lymphoma immunoglobulin VH gene suggests that antigen stimulation plays a role in the clonal expansion
24. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas
25. The t(11;18)(q21;21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type
26. The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
27. Incidence and subtype specificity of AP12-MALT1 fusion translocation in extranodal, nodal, and splenic marginal zone lymphomas
28. The product of the t(11;18), an AP12-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation
29. AP12-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products
30. Heterogeneity of the AP12-MALT1 gene rearrangement in MALT-type lymphoma
31. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
32. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10
33. Identification of paracaspases and metacaspases: Two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma
34. BCL-10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NFκB signaling pathway
35. Cytogenetic study of B cell lymphoma of mucosa-associated lymphoid tissue
36. Novel translocation of the BCL-10 gene in a case of mucosa associated lymphoid tissue lymphoma
37. BCL-10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
38. Inactivating mutations and overexpression of BCL-10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
39. Point mutations and deletions of the BCL-10 gene in solid tumors and malignant lymphomas
40. BCL-10 mutation in lymphoma
41. BCL-10 expression in normal and neoplastic lymphoid tissue: Nuclear localization in MALT lymphoma
42. Regulatory mechanisms of TRAF2-mediated signal transduction by BCL-10, a MALT lymphoma-associated protein
43. Oncogene deregulation in B cell non-Hodgkin's lymphoma: Recent advances
44. BCL-10 Is a positive regulator of antigen receptor-induced activation of NFκB and neural tube closure
45. Bimp1, a MAGUK family member linking protein kinase C activation to BCL-10-mediated NFκB induction
46. Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro
47. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma
48. c-myc gene abnormalities in mucosa associated lymphoid tissue (MALT) lymphomas
49. Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin's lymphoma
50. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas
51. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas
52. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
53. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas
54. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue
55. Long-term follow-up of gastric MALT lymphoma treated by eradication of H pylori with antibodies
56. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: Follow-up study of 48 cases
57. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment
58. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: True relapse or persistence?
59. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
60. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
61. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction, or both?
62. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
63. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: Follow-up together with sequential molecular studies
64. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: An uncontrolled trial
65. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B cell lymphomas of the mucosa-associated lymphoid tissue: Results of an ongoing multicenter trial
66. When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after Helicobacter pylori eradication?
67. Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: A long-term follow-up study
68. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage 1 with Helicobacter pylori eradiction: Long-term results after sequential histologic and molecular follow-up
69. Predective factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment
70. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori
71. Complete remission of primary high-grade B cell gastric lymphoma after cure of Helicobacter pylori infection
72. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease
73. The gastric marginal zone B cell lymphoma of MALT type
74. Low-grade MALT lymphoma of the stomach: A review of treatment options